San Francisco, California (PRWEB) October 14, 2014

Global clinical laboratory services market is expected to reach USD 261.42 billion by 2020, according to a new study by Grand View Research, Inc. The demand for early diagnosis in order to render effective therapeutic interventions is on a constant rise. Wide range of diagnostic tests encompassed in the clinical laboratory services segment coupled with increasing incidence rates of infectious and chronic diseases is expected to drive market growth during the forecast period. In addition, presence of untapped growth opportunities and the rapidly improving healthcare infrastructure in emerging markets such as China, India and Brazil are expected to offer growth opportunities for industry participants.

View full report with TOC at http://www.grandviewresearch.com/industry-analysis/clinical-laboratory-services-market

Clinical chemistry based services dominated the overall market, accounting for over 45.0% of the revenue share in 2013, owing to the fact that these tests are a part of the initial disease diagnostic process and thus are carried out in large volumes.

Request free sample of this report at http://www.grandviewresearch.com/industry-analysis/clinical-laboratory-services-market/request

Further key findings from the study suggest:


Human & tumor genetics followed clinical chemistry tests in terms of revenue. The market for human & tumor genetics is expected to grow at a CAGR of over 6.0% from 2014 to 2020 majorly owing to increasing global incidence rates of cancer.
Stand alone laboratories are expected to witness significant gains over the forecast period. Growing use of these laboratories in emerging and underdeveloped economies in an attempt to improve healthcare access is expected to be the primary growth driver for this segment.
North America dominated the overall clinical laboratory services market in terms of revenue share in 2013, majorly on account of the presence of high prevalence levels of chronic and infectious diseases and sophisticated reimbursement networks.
Asia Pacific is expected to be a high-growth clinical laboratory services market over the forecast period. Growing demand for proper diagnostics and rapidly improving healthcare infrastructure in the emerging markets of China and India are some factors attributing to its rapid growth rate.
Some key market players of clinical laboratory services include Genoptix Medical Laboratory, Quest Diagnostics Inc., LabCorp, Sonic Healthcare, Labco S.A., Charles River Laboratories, Bio-Reference Laboratories, Abbott Laboratories and Healthscope.
The market has witnessed a surge in R&D spending in recent times, aimed at developing technologically advanced products and systems to provide precise result even when dealing with large sample volumes.

Browse all reports of this category at http://www.grandviewresearch.com/industry/clinical-diagnostics

For the purpose of this study, Grand View Research has segmented the global clinical laboratory services market on the basis of test type, service provider and region:

     Global Clinical Laboratory Services Test Outlook (Revenue, USD Billion, 2012 – 2020)
            • Human & Tumor Genetics

            • Clinical Chemistry

            • Medical Microbiology & Cytology

            • Other Esoteric Tests

     Global Clinical Laboratory Services, Service Provider Outlook (Revenue, USD Billion, 2012 – 2020)
            • Hospital-Based Laboratories

            • Stand-Alone Laboratories

            • Clinic-Based Laboratories

     Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2012 – 2020)
            • North America

            • Europe

            • Asia Pacific

            • RoW

Browse all upcoming reports by Grand View Research at http://www.grandviewresearch.com/ongoing-reports

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. For more information, visit http://www.grandviewresearch.com/

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales(at)grandviewresearch(dot)com

Related Reports by Grand View Research

Peripheral Vascular Devices Market Analysis And Segment Forecasts To 2020 – http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market

The global market for peripheral vascular devices is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries.

Pharmaceuticals and Food Anti-Counterfeiting Technologies Market Analysis And Segment Forecasts To 2020 – http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting

The global pharmaceuticals and food anti-counterfeiting market is expected to reach USD 160.32 billion by 2020, according to a new study by Grand View Research, Inc. The rise in the consumption of counterfeit products and the implementation of strict regulations pertaining to anti-counterfeiting by the U.S. FDA are two of the primary growth drivers of this market.






Tags